[{"id":"effe9a5e-e662-41f7-85f9-886424055fe5","acronym":"CHIR-265-MEL01","url":"https://clinicaltrials.gov/study/NCT00304525","created_at":"2021-01-18T01:02:45.140Z","updated_at":"2024-07-02T16:36:37.154Z","phase":"Phase 1/2","brief_title":"A Study to Evaluate RAF265, an Oral Drug Administered to Subjects With Locally Advanced or Metastatic Melanoma","source_id_and_acronym":"NCT00304525 - CHIR-265-MEL01","lead_sponsor":"Novartis Pharmaceuticals","biomarkers":" BRAF • RAS","pipe":" | ","alterations":" BRAF mutation","tags":["BRAF • RAS"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRAF mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e RAF265"],"overall_status":"Completed","enrollment":" Enrollment 104","initiation":"Initiation: 04/01/2006","start_date":" 04/01/2006","primary_txt":" Primary completion: 11/01/2013","primary_completion_date":" 11/01/2013","study_txt":" Completion: 11/01/2013","study_completion_date":" 11/01/2013","last_update_posted":"2020-12-19"},{"id":"0cf566f3-7c3b-40dc-94f4-a2ba85e4d86e","acronym":"","url":"https://clinicaltrials.gov/study/NCT01352273","created_at":"2021-01-18T05:31:38.322Z","updated_at":"2024-07-02T16:36:40.495Z","phase":"Phase 1","brief_title":"MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations","source_id_and_acronym":"NCT01352273","lead_sponsor":"Array Biopharma, now a wholly owned subsidiary of Pfizer","biomarkers":" KRAS • BRAF • NRAS","pipe":" | ","alterations":" BRAF V600E • KRAS mutation • NRAS mutation • BRAF V600","tags":["KRAS • BRAF • NRAS"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRAF V600E • KRAS mutation • NRAS mutation • BRAF V600"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Mektovi (binimetinib) • RAF265"],"overall_status":"Completed","enrollment":" Enrollment 69","initiation":"Initiation: 06/01/2011","start_date":" 06/01/2011","primary_txt":" Primary completion: 09/01/2013","primary_completion_date":" 09/01/2013","study_txt":" Completion: 09/01/2013","study_completion_date":" 09/01/2013","last_update_posted":"2020-09-30"}]